U.S. Stock Futures Steady as Oil Tops $100 Ahead of Inflation Data 
Elon Musk’s Boring Company Raises $3 Billion at $23 Billion Valuation 
Apple Unveils $1,999 Foldable iPhone Duo 
OpenAI Agents Linked to RubyGems Cyberattack 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Trump Threatens Bombardier U.S. Sales Ban 
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 
Trump Administration Releases New UFO Files and Apollo Mission Records 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
Iraq Seeks 6 Million Bpd OPEC+ Oil Quota 
Global Central Banks Brace for More Rate Hikes as Inflation Risks Rise 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
Google Revamps EU Search Results to Meet DMA Rules 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
OpenAI Targets Specialized Industries as Enterprise AI Demand Grows 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Add as a preferred source on Google
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
